Golimumab Subcutaneous and Mydayis ER Capsules
Determining the interaction of Golimumab Subcutaneous and Mydayis ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: amphetamine / dextroamphetamine
Brand name: Adderall, Adderall XR, Mydayis
Synonyms: Mydayis
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Mydfrin
- Golimumab Subcutaneous-Mydfrin Ophthalmic
- Golimumab Subcutaneous-Mydfrin Ophthalmic Solution
- Golimumab Subcutaneous-Mydral Ophthalmic
- Golimumab Subcutaneous-Mydriacyl
- Golimumab Subcutaneous-Mydriacyl Ophthalmic
- Mydayis ER Capsules-GoLYTELY
- Mydayis ER Capsules-Gonadorelin
- Mydayis ER Capsules-Gonadorelin Intravenous, Injection
- Mydayis ER Capsules-Gonadotropin, Chorionic
- Mydayis ER Capsules-Gonal-F
- Mydayis ER Capsules-Gonal-f RFF